SKA3 and laryngeal squamous cell carcinoma: Additionally, as a tumor metabolic regulatory gene, SKA3 can inhibit the ubiquitination and degradation of polo-like kinase 1 (PLK1) protein, resulting in the upregulation of glycolytic enzymes and enhanced glycolysis in laryngeal squamous cell carcinoma [44].